Sponsors Want Therapeutic Experience
On several occasions each year, Industry Standard Research (ISR) has the opportunity to speak with sponsor companies about their outsourcing practices.
On several occasions each year, Industry Standard Research (ISR) has the opportunity to speak with sponsor companies about their outsourcing practices. One common topic is CRO selection. Almost invariably sponsors tell us that Therapeutic Expertise is the single most important criterion for selecting a partner for clinical research. In a recent study, however, we also decided to ask which attributes were becoming more important in their selection of service providers.
ISR's data show that not only is Therapeutic Expertise important in today's environment, it is becoming increasingly so; and if our sample is any indication, Oncology and CNS are the areas of focus.
Requirements Evolve for Service Providers
But here's the real news—and the challenge for CROs—sponsors indicate that they want this additional expertise at lower costs. Alongside Therapeutic Expertise, Low Cost is expected to surge as a significant driver of CRO selection. This finding is new in our research. Historically, low cost has shown up 4th or 5th among selection drivers behind characteristics such as Project Manager Quality and Project Team Chemistry, but this appears to be changing.
As sponsors sharpen their pencils, the pressure will increase on CROs to demonstrate value like never before.—Industry Standard Research, www.ISRreports.com
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
